The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
Clinical trial NCT03858686 · COMPLETED
Trial details
- NCT number
- NCT03858686
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-02
- Primary completion
- 2022-12-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.